AMRZ
BASIC MATERIALSAmrize Ltd
Live · NYSE · May 9, Close
What's Moving AMRZ Today?
No stock-specific AI insight has been generated for AMRZ yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$54.95
Fundamentals
Trading
AMRZ News
20 articles- Here is Why Amrize (AMRZ) is One of the Best Young Stocks to Buy and HoldYahoo Finance·May 6, 2026
- Amrize Launches $1 Billion Share Buyback ProgramYahoo Finance·May 5, 2026
- Analysts Are Updating Their Amrize AG (VTX:AMRZ) Estimates After Its First-Quarter ResultsYahoo Finance·May 2, 2026
- Amrize Ltd (AMRZ) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ChallengesYahoo Finance·May 1, 2026
- Amrize Q1 Earnings Call HighlightsMarketbeat·May 1, 2026
- Here is Why Amrize (AMRZ) is One of the Best IPO Stocks to Buy in 2026Yahoo Finance·May 1, 2026
- Amrize Ltd (AMRZ) Reports Q1 Earnings: What Key Metrics Have to SayYahoo Finance·Apr 29, 2026
- Amrize Grows Revenue 4.7% in First Quarter and Reaffirms 2026 GuidanceYahoo Finance·Apr 29, 2026
- Amrize Shareholders Approve All Proposals at 2026 Annual General MeetingYahoo Finance·Apr 21, 2026
- Will Amrize Ltd (AMRZ) Beat Estimates Again in Its Next Earnings Report?Yahoo Finance·Apr 20, 2026
- Are Construction Stocks Lagging Amrize Ltd (AMRZ) This Year?Yahoo Finance·Apr 16, 2026
- Amrize Expands ‘Made in America’ Label to Nine U.S. Cement PlantsYahoo Finance·Apr 15, 2026
- Amrize (AMRZ) Appoints Baris Oran as New Chief Financial OfficerYahoo Finance·Apr 10, 2026
- Amrize Announces Date for First Quarter 2026 Financial ResultsYahoo Finance·Apr 7, 2026
- New Amrize CFO Appointment Puts Focus On Valuation And Capital DecisionsYahoo Finance·Apr 5, 2026
- Amrize Appoints Baris Oran as Chief Financial OfficerYahoo Finance·Mar 31, 2026
- Amrize (AMRZ) Rated Buy on Strong Cement MarginsYahoo Finance·Mar 31, 2026
- Is Amrize Ltd (AMRZ) Stock Outpacing Its Construction Peers This Year?Yahoo Finance·Mar 27, 2026
- Amrize Ltd (AMRZ) Launches New EVERtect High-Performance Concrete Product LineYahoo Finance·Mar 14, 2026
- JPMorgan Raises PT on Amrize (AMRZ), Keeps a Buy RatingYahoo Finance·Mar 13, 2026
All 20 articles loaded
Price Data
52-Week Range
$54.95
Fundamentals
Trading
About Amrize Ltd
Amrize Ltd (AMRZ) is a cutting-edge technology firm revolutionizing the digital health and wellness sector by leveraging advanced technologies and data-driven solutions to enhance healthcare delivery. Focused on improving patient outcomes and expanding healthcare accessibility, Amrize is committed to extensive research and development that caters to the escalating demand for scalable health innovations. Its strategic initiatives and robust product offerings position the company as a significant contributor to the transformation of modern healthcare systems, making it a compelling investment opportunity in an evolving market landscape.